ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 107 out of 2061

$1.05M Total Retail Price of All Prescriptions

Rank: 111 out of 2061

524 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 524 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 14,702 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
WARFARIN SODIUM 524 487 1 11
FUROSEMIDE 502 452 2 6
OMEPRAZOLE 494 366 3 5
LEVOTHYROXINE SODIUM 484 443 4 3
SIMVASTATIN 481 399 5 1
AMLODIPINE BESYLATE 410 359 6 4
ATORVASTATIN CALCIUM 382 345 7 8
CITALOPRAM HBR 355 319 8 20
METFORMIN HCL 343 272 9 9
LISINOPRIL 319 257 10 2
CARVEDILOL 318 289 11 22
POTASSIUM CHLORIDE 303 245 12 16
PANTOPRAZOLE SODIUM 289 240 13 45
DONEPEZIL HCL 285 282 14 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 272 255 15 27
METOPROLOL TARTRATE 269 252 16 7
CRESTOR 265 243 17 31
ISOSORBIDE MONONITRATE ER 240 231 18 42
GLIMEPIRIDE 237 187 19 33
HYDROCODONE-ACETAMINOPHEN 225 190 S3 20 10
JANUVIA 217 178 21 51
GABAPENTIN 191 126 22 15
POLYETHYLENE GLYCOL 3350 187 154 23 64
CLOPIDOGREL 174 149 24 29
ZOLPIDEM TARTRATE 172 145 25 23
NAPROXEN 172 139 25 110
LOSARTAN POTASSIUM 161 159 27 17
LOSARTAN-HYDROCHLOROTHIAZIDE 146 122 28 50
TAMSULOSIN HCL 144 117 29 30
METOPROLOL SUCCINATE 142 117 30 19
CIPROFLOXACIN HCL 141 130 31 54
ETODOLAC 126 101 32 253
FLUTICASONE PROPIONATE 118 90 33 43
PLAVIX 116 108 34 49
ALENDRONATE SODIUM 115 103 35 25
CEFUROXIME 110 91 36 170
PROAIR HFA 108 63 37 40
PROPRANOLOL HCL 107 85 38 143
OXYCODONE-ACETAMINOPHEN 105 51 S2 39 36
TRAMADOL HCL 103 102 40 18
ZETIA 102 73 41 68
SYNTHROID 101 92 42 58
FENTANYL 99 74 S2 43 84
RANITIDINE HCL 98 75 44 53
PAROXETINE HCL 96 79 45 61
AMLODIPINE BESYLATE-BENAZEPRIL 96 66 45 79
RISPERIDONE 94 94 47 66
NEXIUM 94 66 47 26
LOVASTATIN 91 80 49 35
SERTRALINE HCL 88 77 50 21
ESCITALOPRAM OXALATE 83 80 51 77
NAMENDA 82 81 52 37
CLONIDINE HCL 80 48 53 52
BISOPROLOL-HYDROCHLOROTHIAZIDE 80 56 53 152
DIOVAN HCT 79 79 55 99
DILTIAZEM 24HR CD 75 75 56 118
MECLIZINE HCL 75 72 56 142
FAMOTIDINE 73 62 58 67
JANUMET 71 65 59 180
METHYLPREDNISOLONE 71 53 59 101
FLUOXETINE HCL 67 64 61 73
PRAVASTATIN SODIUM 66 61 62 14
AMIODARONE HCL 63 60 63 168
BYSTOLIC 62 55 64 130
HYDROCHLOROTHIAZIDE 61 44 65 12
QUETIAPINE FUMARATE 61 61 65 72
MIRTAZAPINE 60 58 67 46
LEVETIRACETAM 58 58 68 102
TERBUTALINE SULFATE 58 53 68 426
LIPITOR 58 42 68 70
HYDRALAZINE HCL 57 45 71 69
GLIPIZIDE 57 57 71 55
TRILIPIX 57 35 71 214
NOVOLOG 57 32 71 102
ATENOLOL 56 43 75 13
TRIAMCINOLONE ACETONIDE 56 54 75 172
ONGLYZA 56 38 75 204
ADVAIR DISKUS 54 43 78 57
NASONEX 52 40 79 332
KLOR-CON M20 52 50 79 47
NOVOLOG MIX 70-30 51 34 81 250
PREDNISONE 51 42 81 32
MELOXICAM 50 26 83 44
AZOR 50 26 83 320
CELEBREX 50 48 83 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.